Joseph T.  Kennedy net worth and biography

Joseph Kennedy Biography and Net Worth

General Counsel of Amarin

Joseph Kennedy is the executive vice president, general counsel, and secretary of strategic initiatives at Amarin, roles he has held since 2011. 

Having spent more than 20 years working with life science companies, Kennedy has experience at all stages of development, from the startup phase to IPOs to product commercialization. 

Before Amarin, Kennedy was the vice president and general counsel at Transcept Pharmaceuticals, where he had a key role in negotiating the company’s collaboration with Purdue Pharma and helped obtain FDA approval for the company’s lead product. He previously held the roles of chief legal officer and chief corporate counsel at Eyetech Pharmaceuticals. Kennedy led both Transcept and Eyetech through their public company transitions. 

Kennedy also served as vice president and U.S. counsel for corporate business development at Elan Corporation, a biotechnology company headquartered in Dublin, Ireland. He assisted the company in acquiring technologies and managed legal issues related to collaborations. He also participated in a sale of assets, raising over $2 billion in a restructuring. 

Additionally, he practiced law at Orrick, Herrington & Sutcliffe LLP. 

Kennedy has been honored for his work on numerous occasions, including by Financial Times’ North American Most Innovative Lawyers Awards in 2016, on the Legal500 GC Powerlist: United States 2019, and by the president of Ireland as one of the “Irish Life Science 50,” recognizing Irish-Americans’ contributions to the life science industry.

He earned his bachelor’s degree from Fairfield University and his J.D. from New York Law School.

How do I contact Joseph T. Kennedy?

The corporate mailing address for Mr. Kennedy and other Amarin executives is 77 Sir John Rogerson`s Quay Block C Grand Canal Docklands, Dublin L2, Dublin 2. Amarin can also be reached via phone at (531) 669-9020 and via email at [email protected]. Learn More on Joseph T. Kennedy's contact information.

Has Joseph T. Kennedy been buying or selling shares of Amarin?

Joseph T. Kennedy has not been actively trading shares of Amarin during the last ninety days. Most recently, Joseph T. Kennedy sold 2,709 shares of the business's stock in a transaction on Monday, July 1st. The shares were sold at an average price of $390.40, for a transaction totalling $1,057,593.60. Learn More on Joseph T. Kennedy's trading history.

Who are Amarin's active insiders?

Amarin's insider roster includes Aaron Berg (President & CEO), Michael Kalb (CFO), Joseph Kennedy (General Counsel), Steven Ketchum (Insider), David Stack (Director), and Joseph Zakrzewski (Director). Learn More on Amarin's active insiders.

Joseph T. Kennedy Insider Trading History at Amarin

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/1/2019Sell2,709$390.40$1,057,593.60View SEC Filing Icon  
5/31/2019Sell1,361$358.40$487,782.40View SEC Filing Icon  
4/30/2019Sell1,361$373.80$508,741.80View SEC Filing Icon  
4/1/2019Sell2,708$401.00$1,085,908.00View SEC Filing Icon  
2/28/2019Sell1,361$414.40$563,998.40View SEC Filing Icon  
1/31/2019Sell2,131$349.80$745,423.80View SEC Filing Icon  
1/24/2019Sell52,009$355.40$18,483,998.60View SEC Filing Icon  
1/11/2019Sell158$378.40$59,787.20View SEC Filing Icon  
12/31/2018Sell1,347$269.80$363,420.60View SEC Filing Icon  
11/30/2018Sell1,165$356.20$414,973.00View SEC Filing Icon  
10/31/2018Sell1,165$414.80$483,242.00View SEC Filing Icon  
10/1/2018Sell2,512$336.20$844,534.40View SEC Filing Icon  
9/24/2018Sell53,985$211.20$11,401,632.00View SEC Filing Icon  
7/2/2018Sell1,347$60.00$80,820.00View SEC Filing Icon  
4/3/2018Sell1,347$58.00$78,126.00View SEC Filing Icon  
1/31/2018Sell2,242$74.60$167,253.20View SEC Filing Icon  
1/17/2018Sell2,555$82.00$209,510.00View SEC Filing Icon  
7/3/2017Sell15,395$80.00$1,231,600.00View SEC Filing Icon  
See Full Table

Joseph T. Kennedy Buying and Selling Activity at Amarin

This chart shows Joseph T Kennedy's buying and selling at Amarin by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Amarin Company Overview

Amarin logo
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally to wholesalers and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
Read More

Today's Range

Now: $16.46
Low: $15.69
High: $16.58

50 Day Range

MA: $17.30
Low: $15.20
High: $20.25

2 Week Range

Now: $16.46
Low: $7.08
High: $20.90

Volume

55,382 shs

Average Volume

76,011 shs

Market Capitalization

$342.20 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.71